Cardiothoracic Surgery, University of Virginia, Charlottesville, Va.
Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY.
J Thorac Cardiovasc Surg. 2017 Jun;153(6):1384-1391.e3. doi: 10.1016/j.jtcvs.2016.12.055. Epub 2017 Feb 9.
Pneumonia remains the most common major infection after cardiac surgery despite numerous preventive measures.
To prospectively examine the timing, pathogens, and risk factors, including modifiable management practices, for postoperative pneumonia and estimate its impact on clinical outcomes.
A total of 5158 adult cardiac surgery patients were enrolled prospectively in a cohort study across 10 centers. All infections were adjudicated by an independent committee. Competing risk models were used to assess the association of patient characteristics and management practices with pneumonia within 65 days of surgery. Mortality was assessed by Cox proportional hazards model and length of stay by a multistate model.
The cumulative incidence of pneumonia was 2.4%, 33% of which occurred after discharge. Older age, lower hemoglobin level, chronic obstructive pulmonary disease, steroid use, operative time, and left ventricular assist device/heart transplant were risk factors. Ventilation time (24-48 vs ≤24 hours; hazard ratio [HR], 2.83; 95% confidence interval [95% CI], 1.72-4.66; >48 hours HR, 4.67; 95% CI, 2.70-8.08), nasogastric tubes (HR, 1.80; 95% CI, 1.10-2.94), and each unit of blood cells transfused (HR, 1.16; 95% CI, 1.08-1.26) increased the risk of pneumonia. Prophylactic use of second-generation cephalosporins (HR, 0.66; 95% CI, 0.45-0.97) and platelet transfusions (HR, 0.49, 95% CI, 0.30-0.79) were protective. Pneumonia was associated with a marked increase in mortality (HR, 8.89; 95% CI, 5.02-15.75) and longer length of stay of 13.55 ± 1.95 days (bootstrap 95% CI, 10.31-16.58).
Pneumonia continues to impose a major impact on the health of patients after cardiac surgery. After we adjusted for baseline risk, several specific management practices were associated with pneumonia, which offer targets for quality improvement and further research.
尽管采取了众多预防措施,肺炎仍然是心脏手术后最常见的重大感染。
前瞻性研究术后肺炎的时间、病原体和危险因素,包括可改变的管理实践,并评估其对临床结局的影响。
在 10 个中心进行了一项前瞻性队列研究,共纳入了 5158 例成年心脏手术患者。所有感染均由独立委员会裁定。竞争风险模型用于评估患者特征和管理实践与术后 65 天内肺炎的关系。通过 Cox 比例风险模型评估死亡率,通过多状态模型评估住院时间。
肺炎的累积发病率为 2.4%,其中 33%发生在出院后。年龄较大、血红蛋白水平较低、慢性阻塞性肺疾病、类固醇使用、手术时间、左心室辅助装置/心脏移植是危险因素。通气时间(24-48 小时与≤24 小时;风险比 [HR],2.83;95%置信区间 [95%CI],1.72-4.66;>48 小时 HR,4.67;95%CI,2.70-8.08)、鼻胃管(HR,1.80;95%CI,1.10-2.94)和每单位血细胞输注(HR,1.16;95%CI,1.08-1.26)增加了肺炎的风险。预防性使用第二代头孢菌素(HR,0.66;95%CI,0.45-0.97)和血小板输注(HR,0.49,95%CI,0.30-0.79)具有保护作用。肺炎与死亡率显著增加(HR,8.89;95%CI,5.02-15.75)和住院时间延长 13.55±1.95 天(自举 95%CI,10.31-16.58)相关。
肺炎仍然对心脏手术后患者的健康造成重大影响。在调整了基线风险后,几个特定的管理实践与肺炎有关,这为质量改进和进一步研究提供了目标。